Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 2,574 | 2,590 | 29,095 | 1,886 | 1,927 |
| Gross Profit | 2,574 | 2,590 | 29,095 | 1,886 | 1,927 |
| Operating Expenses | 29,764 | 27,687 | 27,389 | 28,409 | 19,518 |
| Operating Income | -27,190 | -25,097 | 1,705 | -26,523 | -17,591 |
| Other Income | 610 | 4,306 | 448 | 288 | 285 |
| Pre-tax Income | -26,581 | -20,791 | 2,153 | -26,235 | -17,306 |
| Net Income Continuous | -26,581 | -20,791 | 2,153 | -26,235 | -17,306 |
| Net Income | $-26,581 | $-20,791 | $2,153 | $-26,235 | $-17,306 |
| EPS Basic Total Ops | -12.01 | -9.61 | 0.90 | -12.91 | -9.01 |
| EPS Basic Continuous Ops | -12.15 | -9.66 | 1.00 | -12.77 | -9.10 |
| EPS Diluted Total Ops | -12.01 | -9.61 | 0.90 | -12.91 | -9.01 |
| EPS Diluted Continuous Ops | -12.09 | -9.66 | 0.94 | -12.77 | -9.10 |
| EBITDA(a) | $-26,785 | $-24,813 | $2,094 | $-26,370 | $-17,436 |